Thrivent Financial For Lutherans Iovance Biotherapeutics, Inc. Transaction History

Thrivent Financial For Lutherans

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$28.67 - $52.59 $1.35 Million - $2.48 Million	-47,128 Closed	0 $0
Q3 2020 Nov 10, 2020	SELL	$27.75 - $36.3 $76,839 - $100,514	-2,769 Reduced 5.55%	47,128 $1.55 Million
Q1 2020 May 15, 2020	BUY	$19.54 - $38.85 $974,987 - $1.94 Million	49,897 New	49,897 $1.49 Million

313

237M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.21B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

Stay updated on Thrivent Financial For Lutherans with notifications on news.